Targeted Navigation in Hepatocellular Carcinoma (HCC)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Miami
About this trial
The investigators are trying to learn more about the personal perceptions and experiences regarding the needs of patients with liver cancer to help improve the care of all patients. The investigators would like to know whether there are needs that patients have or are aware of, especially those needs that the investigators have not been able to address. The investigators aim to develop a program that helps participants and participant's families to navigate the process of being diagnosed with liver cancer and receiving treatment.
Eligibility criteria
Qualifiers
Enrolled or eligible for enrollment in Unified Prospective Registry and Biorepository of Patients with Chronic Liver Disease or Hepatobiliary Cancers Including Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma.
Diagnosis of hepatocellular carcinoma, confirmed by clinical chart review and International Classification of Diseases, Tenth Revision (ICD-10) C22.0.
Adults, age 18 or older
Able to provide informed consent
Disqualifiers
Unable to speak Spanish or English
West Haven Grade 2 or higher hepatic encephalopathy19 or other cognitive impairment.
Adults unable or unwilling to consent
Individuals who are not yet adults (infants, children, teenagers)
Trial design
Treatments tested in this trial
- Target Navigation Pilot Program
Treatment groups
210 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Miami
Lead sponsor
The V Foundation
Collaborator
Source ClinicalTrials.gov